Pharma’s Top Management Digital Playbook: Navigating Digital Volatility In this episode of Center of Excellence – Pharma 4.0, we explore how top pharmaceutical executives are steering their organizations through an era of digital volatility. The conversation unpacks how leadership vision, cultural transformation, and technology integration are reshaping pharma’s competitive edge in a rapidly evolving landscape. From AI-driven decision-making to digital governance, cybersecurity, and quantum

We talk with Dr. John Gridley, a postdoctoral fellow in the Vaccinology Training Program at Emory University, GA, who uses a hepatitis C virus-related rodent hepacivirus model to identify correlates of protective immunity for HCV and the role of inducible Hepatic-Associated Lymphoid Tissue (iHALT) in the induction of this immune response.

Dr Donald Lyall narrates his blog written for Dementia Researcher. In this guest blog, Donald draws lessons from legendary F1 designer Adrian Newey and the Race Against Dementia summit. Reflecting on Newey’s philosophy of learning from failure, teamwork, data integrity, and time for focused thought, Lyall shows how these principles can inform dementia research. By connecting motorsport precision with scientific collaboration, he highlights how structured creativity and belief in the

The boundary between scientific exchange and marketing in payer presentations is increasingly blurred, creating significant compliance and enforcement risks. While payers demand real-world evidence, comparative studies, and economic models beyond FDA-approved labeling, manufacturers must ensure all shared information is truthful, non-misleading, properly contextualized, and backed by competent and reliable scientific evidence. Key pitfalls include: Cherry-picking data without balanced limitat...

The biochemist, who died last month at age 92, was part of the first neurobiology department in the world and showed that gamma-aminobutyric acid is inhibitory.

Why do we spend a third of our lives unconscious — snoring, drooling, and totally useless to predators — and still survive as a species? (Evolution, seriously, what were you thinking?)In this episode, Roxie dives into the fascinating biology of sleep — what it does for our brains, our bodies, and our sanity. You’ll learn how sleep repairs tissues, clears toxins, strengthens memory, balances mood, and even keeps your immune system in check.This episode connects beautifully with last episode  topic

Dr Kamar Ameen-Ali narrates her blog written for Dementia Researcher.In this blog, Kam reflects on her recent academic sabbatical and what it taught her about the shifting demands of university life. She explores how increasing administrative and teaching duties have transformed the traditional idea of a sabbatical from a period of rest into a vital opportunity to rescue research time. Kamar shares what she achieved, what she learned about productivity and burnout, and how the

IBP - From Chaos to Control In this episode, we dive into how Integrated Business Planning (IBP) is reshaping the pharmaceutical industry by connecting strategy, finance, supply chain, and operations into one unified, intelligent framework. As volatility challenges global pharma networks, IBP offers a path to smarter, faster, and more aligned decisions — transforming disconnected processes into a single source of truth powered by data, AI, and collaboration. Join us as we unpack how top pharma

death, death doula, funerary practices, history of death care, doula bag essentials, coaching for caregivers, end of life care, rituals, grief support, palliative care In this episode of Dear Psychopomp, Anne-Marie delves into the history and evolution of death care, exploring the role of death doulas and the essential items they carry in their doula bags. The conversation highlights the significance of rituals and ceremonies in death care, the transformation of funerary practices over ...

Rachel Chapman recaps her article, “Tube Erosion,” which was written with Matthew Henderson, MD; Dan Arreaza-Kaufman, MD; Jonathan Eisengart, MD; and Mary Qiu, MD, and was featured in the May/June issue of Glaucoma Today. Glaucoma drainage implants can lower IOP and preserve patients’ vision, but the devices carry the risk of tube erosion, a serious complication that requires prompt surgical management. Ms. Chapman reviews the rates of tube erosion, risk factors, strategies for prevention, and

Welcome to a special Halloween episode of Health Science Radio. It opened in 1941 as “the last word in Army hospitals,” serving military families from World War II to Vietnam. Today, the Fitzsimons Building houses the administrative offices of CU Anschutz. It’s not uncommon for the community to ask, “Is the Fitzsimons building haunted?” Those who work in the bowels of the 480,000 square foot art deco building have chilling tales to tell.

This is a free preview of a paid episode. To hear more, visit www.razibkhan.comToday, Razib talks to Coltan Scrivner, a behavioral scientist, horror entertainment producer, and author, whose work centers on the psychological and evolutionary roots of our fascination with darkness, horror, and true crime. He is affiliated with the Department of Psychology at Arizona State University. Scrivner also serves as the executive director of the Nightmare in the Ozarks Film Festival and founded the Eureka

Human-specific duplicates of SRGAP2 prolong cortical development by manipulating SYNGAP, an autism-linked protein that slows synaptic growth.

The rate of smoking cigarettes has steadily declined since the 1960s – when Congress required warnings on cigarette boxes. Research shows that people are more likely to try to quit smoking when they’re under 40. But a new study in the journal The Lancet Healthy Longevity shows that quitting later in life can still be beneficial – and could possibly lower your risk for dementia. For this and more news from the science journals, Short Wave hosts Regina G. Barber and Emily Kwong talk with All Things

In this episode, Roxie dives into the fascinating world of dreams — those strange, vivid, sometimes emotional stories that play out in our minds while we sleep. She explores both the science and the mystery behind dreaming, combining humor, research, and a few wonderfully weird personal anecdotes.Key Topics Covered:What dreams are and when they happen (REM vs. Non-REM sleep)Leading theories of why we dream:🧠 Memory consolidation💭 Emotional processing🎭 Activation-synthesis (random brain noise)⚔️

In this episode, Darshan Kulkarni speaks with Dae Lee about the growing conflict between pharmaceutical manufacturers and pharmacy benefit managers (PBMs) — and how it’s reshaping the U.S. drug supply chain. They unpack the recent dispute involving AstraZeneca, which alleges discrepancies between the number of branded claims submitted by pharmacies through PBMs and the rebates invoiced by those PBMs. The issue shines a spotlight on how PBMs control formulary access and drug distribution, ofte...

About this podcast:This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies for constructing ADCs and the critical differentiating features that enhance therapeutic efficacy and safety. For more information, go to IO360summit.com.

Have you ever wondered if manual therapy is useful in the later stages of rehab?  In this episode< Dr. Zach Baker and Dr. Corrie Jones talk about times and situations where manual therapy really can be helpful during those bridge phases in leaning towards performance and return to sport.  There are definitely appropriate times and places where this can be something the keeps your athletes on-track and helps ensure progression through the phases.  Listen in to hear what years of experience and

Nociceptors tamp down the production of reactive oxygen species in response to heat, chemical irritants or toxins.

In this QCast episode, Jullia and Tom unpack real-world evidence in modern drug development — what distinguishes real-world data from the evidence it enables, and how to apply it alongside randomised trials.Key TakeawaysStart with the decision, emulate the target trial, and justify methods with clear diagnostics.Make data fitness and governance non-negotiable: provenance, completeness, traceability, privacy, and compliant linkage.Use RWE to complement trials; for external controls, ensure clinical